In Response to "Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations"

J Clin Oncol. 2020 Dec 20;38(36):4352. doi: 10.1200/JCO.20.02253. Epub 2020 Oct 30.

Authors

Steven A Narod¹, Vasily Giannakeas¹

Affiliation

¹ Steven A. Narod, MD, and Vasily Giannakeas, MPH, Dalla Lana School of Public Health, University of Toronto; and Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

PMID: 33125308
DOI: 10.1200/JCO.20.02253

No abstract available

Publication types

Letter
Comment

MeSH terms

BRCA2 Protein / genetics
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Female
Germ Cells
Germ-Line Mutation
Humans
Pregnancy

Substances

BRCA2 Protein